ArticleDiscover oncology2026

Synthesis and pharmacokinetic profiling of a novel pyrimidine imidazole based thiosemicarbazone derivative for BRAF inhibition in lung cancer therapy.

Yavuz Ekincioğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.